-
- Comment in:
-
Nat Genet. 1995 Feb;9(2):101-3.
FGFR2 mutations in Pfeiffer syndrome.
PMID: 7719333 [PubMed - indexed for MEDLINE]
-
Cited by 18 PubMed Central articles
-
Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.
Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, Tomkins S, Verloes A, Twigg SR, Rannan-Eliya S, et al.
Am J Hum Genet. 2002 Feb; 70(2):472-86. Epub 2002 Jan 4.
[Am J Hum Genet. 2002]
-
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome.
Yu K, Herr AB, Waksman G, Ornitz DM.
Proc Natl Acad Sci U S A. 2000 Dec 19; 97(26):14536-41.
[Proc Natl Acad Sci U S A. 2000]
-
De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome.
Oldridge M, Zackai EH, McDonald-McGinn DM, Iseki S, Morriss-Kay GM, Twigg SR, Johnson D, Wall SA, Jiang W, Theda C, et al.
Am J Hum Genet. 1999 Feb; 64(2):446-61.
[Am J Hum Genet. 1999]
- » See all...